Nephros, Inc. (NEPH)
| Market Cap | 35.45M |
| Revenue (ttm) | 18.79M |
| Net Income (ttm) | 1.19M |
| Shares Out | 10.64M |
| EPS (ttm) | 0.11 |
| PE Ratio | 30.45 |
| Forward PE | 55.83 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,298 |
| Open | 3.170 |
| Previous Close | 3.230 |
| Day's Range | 3.010 - 3.370 |
| 52-Week Range | 1.640 - 6.420 |
| Beta | 1.56 |
| Analysts | Strong Buy |
| Price Target | 6.00 (+80.18%) |
| Earnings Date | May 8, 2026 |
About NEPH
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that ... [Read more]
Financial Performance
In 2025, Nephros's revenue was $18.79 million, an increase of 32.67% compared to the previous year's $14.16 million. Earnings were $1.19 million, an increase of 1513.51%.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for NEPH stock is "Strong Buy" and the 12-month stock price target is $6.0.
News
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
SOUTH ORANGE, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today anno...
Nephros Earnings Call Transcript: Q4 2025
Revenue grew 33% to $18.8M in 2025 with net income of $1.2M, driven by programmatic sales and service expansion. Gross margin held at 62% for the year despite tariff pressures, and the company remains debt-free with $5.4M in cash.
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March ...
Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call
SOUTH ORANGE, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today anno...
Nephros Earnings Call Transcript: Q3 2025
Q3 2025 revenue rose 35% year-over-year to $4.8M, marking the fifth consecutive profitable quarter, with strong growth in programmatic and service revenue. New PFAS solutions and expansion into non-hospital verticals are expected to drive future growth.
Nephros Schedules Third Quarter 2025 Financial Results Conference Call
SOUTH ORANGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today annou...
Nephros Earnings Call Transcript: Q2 2025
Q2 2025 saw 36% revenue growth and the third straight quarter of profitability, driven by strong programmatic sales, record customer retention, and margin improvements. Expansion into new verticals and innovations like the filter tracking app are fueling sustainable growth.
Nephros Announces Strong Second Quarter Financial Results
SOUTH ORANGE, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today annou...
Nephros Schedules Second Quarter 2025 Financial Results Conference Call
SOUTH ORANGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today annou...
Nephros Earnings Call Transcript: Q4 2024
Q4 2024 saw 19% sales growth and a return to profitability, driven by core business expansion and new product launches. Gross margins improved, and the company ended the year debt-free with a strong cash position, setting the stage for growth in 2025.
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC
SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today annou...
Nephros Earnings Call Transcript: Q3 2024
Q3 2024 marked the first profitable quarter, with net income of $0.2M and gross margin rising to 61%. Revenue was $3.5M, up 8% sequentially but down 6% year-over-year, as cost controls and operational improvements offset programmatic declines.
Nephros Schedules Third Quarter 2024 Financial Results Conference Call
SOUTH ORANGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today ...
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton
SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurr...
Nephros Earnings Call Transcript: Q2 2024
Q2 2024 saw strong growth in core programmatic business and record customer sites, but total revenue declined 8% due to a sharp drop in emergency response sales. Gross margins remained robust, and net loss improved significantly year-over-year.
Nephros Announces Financial Results for Quarter Ended June 30, 2024
Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading wat...
Nephros Schedules Second Quarter 2024 Financial Results Conference Call
SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today an...
Nephros Earnings Call Transcript: Q1 2024
Nephros Earnings Call Transcript: Q4 2023
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading wa...
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial mar...
Nephros Earnings Call Transcript: Q3 2023
Nephros Announces Results for Quarter Ended September 30, 2023
Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from Operatin...
Nephros Hires Judy Krandel as Chief Financial Officer
SOUTH ORANGE, NJ, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial mar...
Nephros Schedules Third Quarter 2023 Financial Results Conference Call
SOUTH ORANGE, NJ, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial mar...